EFFECT OF ALPHA-1-PROTEINASE INHIBITOR ON NEUTROPHIL CHEMOTAXIS

被引:51
|
作者
STOCKLEY, RA
SHAW, J
AFFORD, SC
MORRISON, HM
BURNETT, D
机构
[1] Lung Immunobiochemical Research Laboratory, General Hospital, Birmingham
关键词
D O I
10.1165/ajrcmb/2.2.163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factors that modulate neutrophil migration into the lung are poorly understood. However, there is evidence that neutrophil activation by formylmethionylleucylphenylalanine (FMLP) depends upon a surface proteinase with chymotrypsin-like activity. This suggests that chymotrypsin inhibitors such as alpha-1-proteinase inhibitor (alpha 1PI) could modify neutrophil migration in response to FMLP. We have studied neutrophil chemotaxis using the multiple blind well assay system. This article presents evidence that alpha 1PI is an inhibitor of neutrophil migration in response to FMLP. The effect is related to the inhibitory function of the protein. Alpha-1-antichymotrypsin is more potent than alpha 1PI as an inhibitor of this movement, whereas antileukoprotease is less potent. The results suggest that a cell membrane-bound serine proteinase (perhaps cathepsin G) is necessary for the enhancement of cell movement after receptor binding of FMLP. Oxidized alpha 1PI or a 4,000-D peptide cleaved from alpha 1PI by porcine pancreatic elastase or human neutrophil elastase are capable of enhancing cell motility. The results suggest that alpha 1PI may play a role in cell migration into the lung during acute inflammatory process.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 50 条
  • [31] OXIDATION OF ALPHA-1-PROTEINASE INHIBITOR - SIGNIFICANCE FOR PATHOBIOLOGY
    TRAVIS, J
    BEATTY, K
    MATHESON, N
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1984, 167 : 89 - 95
  • [32] PAIN AND CYANOSIS ASSOCIATED WITH ALPHA-1-PROTEINASE INHIBITOR
    CLARK, JA
    GROSS, TP
    AMERICAN JOURNAL OF MEDICINE, 1992, 92 (06): : 621 - 626
  • [33] ALPHA-1-PROTEINASE INHIBITOR AND MUCUS PROTEINASE-INHIBITOR IN HUMAN LUNG EMPHYSEMA
    TREFZ, G
    SCHLIESSER, J
    HECK, B
    SCHULZ, V
    EBERT, W
    CLINICAL INVESTIGATOR, 1992, 70 (3-4): : 269 - 276
  • [34] PROTEOLYTIC INACTIVATION OF ALPHA-1-PROTEINASE INHIBITOR AND ALPHA-1-ANTICHYMOTRYPSIN BY OXIDATIVELY ACTIVATED HUMAN NEUTROPHIL METALLOPROTEINASES
    DESROCHERS, PE
    MOOKHTIAR, K
    VANWART, HE
    HASTY, KA
    WEISS, SJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (07) : 5005 - 5012
  • [35] EFFECT OF STORAGE ON ALPHA-1-PROTEINASE INHIBITOR FUNCTION IN BIOLOGICAL-FLUIDS
    AFFORD, SC
    BURNETT, D
    STOCKLEY, RA
    CLINICAL SCIENCE, 1987, 73 : P19 - P19
  • [36] CORNEAL SYNTHESIS OF ALPHA-1-PROTEINASE INHIBITOR (ALPHA-1-ANTITRYPSIN)
    TWINING, SS
    FUKUCHI, T
    YUE, BYJT
    WILSON, PM
    BOSKOVIC, G
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (02) : 458 - 462
  • [37] COMPARISON OF THE EFFECTS OF PURIFIED HUMAN ALPHA-1-ANTICHYMOTRYPSIN AND ALPHA-1-PROTEINASE INHIBITOR ON NK CYTOTOXICITY - ONLY ALPHA-1-PROTEINASE INHIBITOR INHIBITS NATURAL KILLING
    LAINE, A
    LEROY, A
    HACHULLA, E
    DAVRIL, M
    DESSAINT, JP
    CLINICA CHIMICA ACTA, 1990, 190 (03) : 163 - 173
  • [38] THE EFFECT OF ALPHA-2-MACROGLOBULIN ON THE INTERACTION OF ALPHA-1-PROTEINASE INHIBITOR WITH PORCINE TRYPSIN
    BEATTY, K
    TRAVIS, J
    BIETH, J
    BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 704 (02) : 221 - 226
  • [39] DECREASE IN THE LEVEL OF ALPHA-1-PROTEINASE INHIBITOR IS NOT SPECIFIC TO KERATOCONUS
    PANJWANI, N
    ZAIDI, TS
    HASAN, A
    CLARK, B
    BAUM, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 1068 - 1068
  • [40] PRODUCTION OF ALPHA-1-PROTEINASE INHIBITOR BY THE HUMAN ALVEOLAR MACROPHAGE
    FUJITA, J
    ERTL, RF
    VAUGHAN, WP
    CHRISTENSEN, KR
    RENNARD, SI
    CLINICAL RESEARCH, 1986, 34 (04): : A934 - A934